Sandoz Group AG
Sandoz Group AG (SDZ.SW) Stock Competitors & Peer Comparison
See (SDZ.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SDZ.SW | CHF 61.68 | +0.78% | 26.7B | 37.80 | CHF 1.63 | +0.97% |
| EVT.SW | CHF 26.96 | N/A | 4.8B | -25.92 | -CHF 1.04 | N/A |
| SFZN.SW | CHF 77.90 | -1.64% | 3.4B | 20.39 | CHF 3.84 | +0.49% |
| PPGN.SW | CHF 23.90 | -2.45% | 879.2M | -28.35 | -CHF 0.94 | N/A |
| CURN.SW | CHF 23.90 | -8.08% | 119.9M | -27.74 | -CHF 0.84 | N/A |
| VIFN.SW | CHF 166.15 | +0.48% | 0 | N/A | N/A | N/A |
| MER.SW | CHF 102.20 | +0.00% | 0 | 14.20 | CHF 7.20 | N/A |
Stock Comparison
SDZ.SW vs EVT.SW Comparison March 2026
SDZ.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SDZ.SW stands at 26.7B. In comparison, EVT.SW has a market cap of 4.8B. Regarding current trading prices, SDZ.SW is priced at CHF 61.68, while EVT.SW trades at CHF 26.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SDZ.SW currently has a P/E ratio of 37.80, whereas EVT.SW's P/E ratio is -25.92. In terms of profitability, SDZ.SW's ROE is +0.10%, compared to EVT.SW's ROE of -0.18%. Regarding short-term risk, SDZ.SW is more volatile compared to EVT.SW. This indicates potentially higher risk in terms of short-term price fluctuations for SDZ.SW.Check EVT.SW's competition here